Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Kris

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Lung cancer cure, care, and cost: let the data be your guideM G Kris
Seminars in Oncology|August 1, 1992
Rationale for combination antiemetic therapy and strategies for the use of ondansetron in combinationsM G Kris
Seminars in Oncology|August 15, 1998
What does chemotherapy have to offer patients with advanced-stage non-small cell lung cancer?M G Kris
Cancer Investigation|January 1, 1988
Peaks, valleys, and plateaus in small cell lung cancerM G Kris
Important Advances in Oncology|January 1, 1994
Ondansetron: a specific serotonin antagonist for the prevention of chemotherapy-induced vomitingM G Kris
Seminars in Oncology|August 1, 1992
Phase II trials of ondansetron with high-dose cisplatinM G Kris
Seminars in Oncology|August 7, 1999
Docetaxel (Taxotere) in the treatment of non-small cell lung cancerM G Kris, M Millward
Seminars in Oncology|April 4, 2001
Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: an international updateM G Kris, C Manegold
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Tropisetron (ICS 205-930): a selective 5-hydroxytryptamine antagonistM G Kris, L B Tyson
Seminars in Oncology|May 16, 2000
Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancerV A Miller, M G Kris
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 1997
Lung cancer cure, care, and cost: let the data be your guideM G Kris
Seminars in Oncology|August 1, 1992
Rationale for combination antiemetic therapy and strategies for the use of ondansetron in combinationsM G Kris
Seminars in Oncology|August 15, 1998
What does chemotherapy have to offer patients with advanced-stage non-small cell lung cancer?M G Kris
Cancer Investigation|January 1, 1988
Peaks, valleys, and plateaus in small cell lung cancerM G Kris
Important Advances in Oncology|January 1, 1994
Ondansetron: a specific serotonin antagonist for the prevention of chemotherapy-induced vomitingM G Kris
Seminars in Oncology|August 1, 1992
Phase II trials of ondansetron with high-dose cisplatinM G Kris
Seminars in Oncology|August 7, 1999
Docetaxel (Taxotere) in the treatment of non-small cell lung cancerM G Kris, M Millward
Seminars in Oncology|April 4, 2001
Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: an international updateM G Kris, C Manegold
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Tropisetron (ICS 205-930): a selective 5-hydroxytryptamine antagonistM G Kris, L B Tyson
Seminars in Oncology|May 16, 2000
Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancerV A Miller, M G Kris
Pageof 16